Skip to main content
. 2013 Jun;16(6):529–537. doi: 10.1089/jmf.2012.0178

Table 5.

Summary of Analysis of Adverse Events in All Subjects

 
 
Severity
 
 
  Number of AEs Mild Moderate Severe Subjects reporting AEs Treatment related
Placebo 5 5 0 0 5 None
Meratrim 5 5 0 0 4 None

Common adverse events (AEs) reported were headache, nausea, gastrointestinal irritation, general weakness, back, leg, ankle, and joint pain.